Araştırma Makalesi
BibTex RIS Kaynak Göster

Yıl 2024, Cilt: 4 Sayı: 1, 11 - 16, 14.05.2024

Adil Gümüş Pınar Pelin Özcan Zehra Pınar Koç Mahmut Süleymanoğlu Emine Aydın Gökçe Yavan

Öz

Kaynakça

  • Cheung, F., Alam, N., & Wright, G. (2018). Pulmonary metastasectomy: analysis of survival and prognostic factors in 243 patients. ANZ journal of surgery, 88(12), 1316–1321. https://doi.org/10.1111/ans.14811
  • Carter CL , Allen C , Henson DE . 24.740 meme kanseri vakasında tümör boyutu, lenf nodu durumu ve hayatta kalma ilişkisi . Kanser . 1989 ; 63 : 181-187 .
  • Kolodziejski L , Goralczyk J , Dyczek S , Duda K , Dymek H , Nabialek T. Akciğer metastazı olan hastalarda cerrahi tedavi endikasyonlarının ve sonuçlarının analizi . Pnömonol Alergol Pol . 1999 ; 67 : 228 – 236 .
  • Tanaka F, Li M, Hanaoka N et al. Surgery for pulmonary nodules in breast cancer patients. Ann Thorac Surg 2005;79:1711-1714. https://doi.org/10.1016/j.athoracsur.2004.10.033 Rena O, Papalia E, Ruffini E et al. The role of surgery in the management of solitary pulmonary nodule in breast cancer patients. Eur J Surg Oncol 2007;33:546-550. http://dx.doi.org/10.1016/j.ejso.2006.12.015
  • McCormack, P. M., Burt, M. E., Bains, M. S., Martini, N., Rusch, V. W., & Ginsberg, R. J. (1992). Lung resection for colorectal metastases. 10-year results. Archives of surgery (Chicago, Ill. : 1960), 127(12), 1403–1406. https://doi.org/10.1001/archsurg.1992.01420120037006
  • Leong, P. P., Rezai, B., Koch, W. M., Reed, A., Eisele, D., Lee, D. J., Sidransky, D., Jen, J., & Westra, W. H. (1998). Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. Journal of the National Cancer Institute, 90(13), 972–977. https://doi.org/10.1093/jnci/90.13.972
  • Askin F. B. (1993). Something old? Something new? Second primary or pulmonary metastasis in the patient with known extrathoracic carcinoma. American journal of clinical pathology, 100(1), 4–5. https://doi.org/10.1093/ajcp/100.1.4
  • Adkins, P. C., Wesselhoeft, C. W., Jr, Newman, W., & Blades, B. (1968). Thoracotomy on the patient with previous malignancy: metastasis or new primary?. The Journal of thoracic and cardiovascular surgery, 56(3), 351–361.
  • Shepherd M. P. (1982). Thoracic metastases. Thorax, 37(5), 366–370. https://doi.org/10.1136/thx.37.5.366
  • Kirienko, M., Cozzi, L., Rossi, A., Voulaz, E., Antunovic, L., Fogliata, A., Chiti, A., & Sollini, M. (2018). Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions. European journal of nuclear medicine and molecular imaging, 45(10), 1649–1660. https://doi.org/10.1007/s00259-018-3987-2
  • Koç, Z. P., Özcan, P. P., Ayan, E., & Bozdoğan Arpacı, R. (2020). Metabolic Characterization of Anterior Mediastinal Masses by 18F-FDG PET/CT. 18F-FDG PET/BT ile Anterior Mediastinal Kitlelerin Metabolik Karakterizasyonu. Molecular imaging and radionuclide therapy, 29(3), 105–111. https://doi.org/10.4274/mirt.galenos.2020.05657
  • Stefanidis, K., Bellos, I., Konstantelou, E., Yusuf, G., Hardavella, G., Jacob, T., Goldman, A., Senbanjo, T., & Vlahos, I. (2024). 18F-FDG PET/CT anatomic and metabolic guidance in CT-guided lung biopsies. European journal of radiology, 171, 111315. https://doi.org/10.1016/j.ejrad.2024.111315

Contribution of FDG PET/CT to Patient Management in Thorax and Mediastinum Masses in Patients with Known Extra-Thorax Malignancy

Yıl 2024, Cilt: 4 Sayı: 1, 11 - 16, 14.05.2024

Adil Gümüş Pınar Pelin Özcan Zehra Pınar Koç Mahmut Süleymanoğlu Emine Aydın Gökçe Yavan

Öz

In patients with known extrathoracic malignancy, the differential diagnosis of thorax and mediastinal masses or pleural fluid detected on FDG PET-CT examinations as primary tumor metastasis or secondary malignancy is of clinical importance. In this study, the contribution of FDG PET-CT examination in differential diagnosis was investigated.

Anahtar Kelimeler

thorax mediastinum mass FDG PET/CT

Kaynakça

  • Cheung, F., Alam, N., & Wright, G. (2018). Pulmonary metastasectomy: analysis of survival and prognostic factors in 243 patients. ANZ journal of surgery, 88(12), 1316–1321. https://doi.org/10.1111/ans.14811
  • Carter CL , Allen C , Henson DE . 24.740 meme kanseri vakasında tümör boyutu, lenf nodu durumu ve hayatta kalma ilişkisi . Kanser . 1989 ; 63 : 181-187 .
  • Kolodziejski L , Goralczyk J , Dyczek S , Duda K , Dymek H , Nabialek T. Akciğer metastazı olan hastalarda cerrahi tedavi endikasyonlarının ve sonuçlarının analizi . Pnömonol Alergol Pol . 1999 ; 67 : 228 – 236 .
  • Tanaka F, Li M, Hanaoka N et al. Surgery for pulmonary nodules in breast cancer patients. Ann Thorac Surg 2005;79:1711-1714. https://doi.org/10.1016/j.athoracsur.2004.10.033 Rena O, Papalia E, Ruffini E et al. The role of surgery in the management of solitary pulmonary nodule in breast cancer patients. Eur J Surg Oncol 2007;33:546-550. http://dx.doi.org/10.1016/j.ejso.2006.12.015
  • McCormack, P. M., Burt, M. E., Bains, M. S., Martini, N., Rusch, V. W., & Ginsberg, R. J. (1992). Lung resection for colorectal metastases. 10-year results. Archives of surgery (Chicago, Ill. : 1960), 127(12), 1403–1406. https://doi.org/10.1001/archsurg.1992.01420120037006
  • Leong, P. P., Rezai, B., Koch, W. M., Reed, A., Eisele, D., Lee, D. J., Sidransky, D., Jen, J., & Westra, W. H. (1998). Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. Journal of the National Cancer Institute, 90(13), 972–977. https://doi.org/10.1093/jnci/90.13.972
  • Askin F. B. (1993). Something old? Something new? Second primary or pulmonary metastasis in the patient with known extrathoracic carcinoma. American journal of clinical pathology, 100(1), 4–5. https://doi.org/10.1093/ajcp/100.1.4
  • Adkins, P. C., Wesselhoeft, C. W., Jr, Newman, W., & Blades, B. (1968). Thoracotomy on the patient with previous malignancy: metastasis or new primary?. The Journal of thoracic and cardiovascular surgery, 56(3), 351–361.
  • Shepherd M. P. (1982). Thoracic metastases. Thorax, 37(5), 366–370. https://doi.org/10.1136/thx.37.5.366
  • Kirienko, M., Cozzi, L., Rossi, A., Voulaz, E., Antunovic, L., Fogliata, A., Chiti, A., & Sollini, M. (2018). Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions. European journal of nuclear medicine and molecular imaging, 45(10), 1649–1660. https://doi.org/10.1007/s00259-018-3987-2
  • Koç, Z. P., Özcan, P. P., Ayan, E., & Bozdoğan Arpacı, R. (2020). Metabolic Characterization of Anterior Mediastinal Masses by 18F-FDG PET/CT. 18F-FDG PET/BT ile Anterior Mediastinal Kitlelerin Metabolik Karakterizasyonu. Molecular imaging and radionuclide therapy, 29(3), 105–111. https://doi.org/10.4274/mirt.galenos.2020.05657
  • Stefanidis, K., Bellos, I., Konstantelou, E., Yusuf, G., Hardavella, G., Jacob, T., Goldman, A., Senbanjo, T., & Vlahos, I. (2024). 18F-FDG PET/CT anatomic and metabolic guidance in CT-guided lung biopsies. European journal of radiology, 171, 111315. https://doi.org/10.1016/j.ejrad.2024.111315
Toplam 12 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Nükleer Tıp, Onkoloji ve Karsinogenez (Diğer)
Bölüm Research Articles
Yazarlar

Adil Gümüş

Pınar Pelin Özcan

Zehra Pınar Koç

Mahmut Süleymanoğlu Bu kişi benim

Emine Aydın Bu kişi benim

Gökçe Yavan 0000-0002-7332-6293

Yayımlanma Tarihi 14 Mayıs 2024
Gönderilme Tarihi 8 Nisan 2024
Kabul Tarihi 13 Mayıs 2024
Yayımlandığı Sayı Yıl 2024 Cilt: 4 Sayı: 1

Kaynak Göster

APA Gümüş, A., Özcan, P. P., Koç, Z. P., Süleymanoğlu, M., vd. (2024). Contribution of FDG PET/CT to Patient Management in Thorax and Mediastinum Masses in Patients with Known Extra-Thorax Malignancy. Molecular Oncologic Imaging, 4(1), 11-16.
AMA Gümüş A, Özcan PP, Koç ZP, Süleymanoğlu M, Aydın E, Yavan G. Contribution of FDG PET/CT to Patient Management in Thorax and Mediastinum Masses in Patients with Known Extra-Thorax Malignancy. Molecular Oncologic Imaging. Mayıs 2024;4(1):11-16.
Chicago Gümüş, Adil, Pınar Pelin Özcan, Zehra Pınar Koç, Mahmut Süleymanoğlu, Emine Aydın, ve Gökçe Yavan. “Contribution of FDG PET/CT to Patient Management in Thorax and Mediastinum Masses in Patients With Known Extra-Thorax Malignancy”. Molecular Oncologic Imaging 4, sy. 1 (Mayıs 2024): 11-16.
EndNote Gümüş A, Özcan PP, Koç ZP, Süleymanoğlu M, Aydın E, Yavan G (01 Mayıs 2024) Contribution of FDG PET/CT to Patient Management in Thorax and Mediastinum Masses in Patients with Known Extra-Thorax Malignancy. Molecular Oncologic Imaging 4 1 11–16.
IEEE A. Gümüş, P. P. Özcan, Z. P. Koç, M. Süleymanoğlu, E. Aydın, ve G. Yavan, “Contribution of FDG PET/CT to Patient Management in Thorax and Mediastinum Masses in Patients with Known Extra-Thorax Malignancy”, Molecular Oncologic Imaging, c. 4, sy. 1, ss. 11–16, 2024.
ISNAD Gümüş, Adil vd. “Contribution of FDG PET/CT to Patient Management in Thorax and Mediastinum Masses in Patients With Known Extra-Thorax Malignancy”. Molecular Oncologic Imaging 4/1 (Mayıs 2024), 11-16.
JAMA Gümüş A, Özcan PP, Koç ZP, Süleymanoğlu M, Aydın E, Yavan G. Contribution of FDG PET/CT to Patient Management in Thorax and Mediastinum Masses in Patients with Known Extra-Thorax Malignancy. Molecular Oncologic Imaging. 2024;4:11–16.
MLA Gümüş, Adil vd. “Contribution of FDG PET/CT to Patient Management in Thorax and Mediastinum Masses in Patients With Known Extra-Thorax Malignancy”. Molecular Oncologic Imaging, c. 4, sy. 1, 2024, ss. 11-16.
Vancouver Gümüş A, Özcan PP, Koç ZP, Süleymanoğlu M, Aydın E, Yavan G. Contribution of FDG PET/CT to Patient Management in Thorax and Mediastinum Masses in Patients with Known Extra-Thorax Malignancy. Molecular Oncologic Imaging. 2024;4(1):11-6.